Get Live Data
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. B8F.L Share Price
  4. B8F.L Share Regulatory News

Pin to quick picksB8F.L Regulatory News (B8F)

B8F.L Information
  • There is currently no data for B8F
12
Date   Source Headline
16th Feb 20161:58 pmRNSPrivate Placement
11th Feb 20163:30 pmRNSPhase III studies update
28th Jan 201610:28 amRNSExcellent results in Ameluz BCC clinical study
26th Jan 20169:49 amRNSFDA completes Ameluz NDA mid-cycle review
20th Jan 20167:00 amRNSNotice of Cancellation from Trading on AIM
7th Jan 20167:00 amRNSCE Marking Granted for IndoorLux® Collaboration
31st Dec 201511:57 amRNSTotal Voting Rights
23rd Dec 20152:30 pmRNSFDA Grants Small Business Waiver of US$2.3m
10th Dec 20157:00 amRNSIssue of equity and total voting rights
7th Dec 20157:00 amRNSMarketing approval for Ameluz® in Switzerland
23rd Nov 20153:05 pmRNSResult of Open Offer and Private Placement
20th Nov 20157:00 amRNS3rd Quarter Report
19th Nov 20158:00 amRNSFinal patient visit in Phase III trial for BCC
12th Nov 20151:00 pmRNSNotice of Q3 Results
11th Nov 201512:00 pmRNSBusiness Operations on Track
5th Nov 201511:32 amRNSFurther re: Subscription Price of New Shares
28th Oct 20153:23 pmRNSFurther re: Open Offer and Private Placement
27th Oct 201511:31 amRNSOpen Offer and Private Placement
2nd Oct 20157:00 amRNSFDA shortens review period for Ameluz
22nd Sep 20157:00 amRNSExcellent long term results of Phase III trial
14th Sep 20157:00 amRNSFDA accepts filing of Ameluz® and BF-RhodoLED®
1st Sep 20157:03 amRNSResult of AGM
14th Aug 20157:00 amRNSHalf Year Results
7th Aug 20157:00 amRNSNotice of Results
22nd Jul 20157:00 amRNSAppointment of Chief Commercial Officer
20th Jul 20157:00 amRNSBelixos® Protect product launch
17th Jul 20157:00 amRNSNotice of AGM
13th Jul 20159:45 amRNSFDA New Drug Application submitted for Ameluz®
22nd Jun 20157:00 amRNSFinal stage completed ahead of FDA submission
19th Jun 20156:10 pmRNSIssue of equity and total voting rights
29th May 20157:00 amRNSStrong Performance for Q1 2015
28th May 20157:00 amRNSResult of Open Offer & Private Placement
26th May 20157:01 amRNSNotice of First Quarter Results 2015
6th May 20157:02 amRNSPublication of PIII Study for Actinic Keratosis
27th Apr 20152:58 pmRNSFurther re Open Offer and Private Placement
23rd Apr 20151:36 pmRNSOpen Offer and Private Placement
20th Apr 20157:00 amRNSUS subsidiary and CEO US Operations Appointed
17th Apr 20157:00 amRNSQ1 Preliminary Trading Update
10th Apr 20157:00 amRNSFinal Results
8th Apr 20157:00 amRNSOff Market Block Trade Completed
30th Mar 20157:00 amRNSNotice of Results
25th Mar 20157:00 amRNSSales and Marketing of Ameluz® in Spain
26th Jan 20157:00 amRNSAmeluz Belgium launch and Clinical Trials Update
22nd Jan 20158:00 amRNSChange of Adviser
5th Dec 20149:00 amRNSBelixos(R) Gel addition to derma product range
26th Nov 20147:00 amRNSAmeluz International Approval Procedure
13th Nov 20147:00 amRNS3rd Quarter Results - 9mnths to 30 Sept 2014
7th Nov 20148:20 amRNSAmeluz distribution for Spanish market
27th Oct 201410:00 amRNSNotice of Q3 Results
20th Oct 20147:00 amRNSChange of Adviser
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
ELE
ELE.L
LSE
0.00%
0ACY
Tui N Ord
LSE
0.00%
MES
MES.L
LSE
0.00%
CAB
Cabot Energy
LSE
0.00%
DEVC
DEVC.L
LSE
0.00%
Trending
MAC
Marechale Cap.
LSE
39.73%
HE1
Helium One
LSE
6.28%
GEX
Georgina Energy
LSE
7.63%
ALRT
Defence Holdings
LSE
-2.38%
NEO
Neo Energy Metals
LSE
-7.30%